LYMPHOPROLIFERATIVE SYNDROME 1
|
disease |
|
Disease or Syndrome
|
1
|
3
|
0.700 |
definitive |
1.000 |
7 |
3
|
1997 |
2015 |
Lymphoproliferative Syndrome, Ebv-Associated, Autosomal, 1
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
|
0.300 |
None |
|
0 |
|
|
|
ITK Deficiency
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
4
|
|
0.310 |
strong |
1.000 |
2 |
|
2011 |
2019 |
Cholesteatoma, Congenital
|
disease |
Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
WHIM syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Infections; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
10
|
7
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Lymphomatoid Granulomatosis
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
11
|
1
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
HODGKIN'S AND NON-HODGKIN'S LYMPHOMA
|
disease |
|
Neoplastic Process
|
17
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Personality Traits
|
group |
Behavior and Behavior Mechanisms
|
Finding
|
24
|
78
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Hemophagocytic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
25
|
3
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Anaplastic large cell lymphoma, ALK negative
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
28
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Middle Ear Cholesteatoma
|
disease |
Skin and Connective Tissue Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
ESR raised
|
phenotype |
|
Finding
|
36
|
|
0.100 |
None |
|
0 |
|
|
|
X-Linked Lymphoproliferative Disorder
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
49
|
10
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2014 |
Epidermodysplasia Verruciformis
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
64
|
9
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
X-linked agammaglobulinemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
68
|
69
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Autoimmune state
|
phenotype |
|
Pathologic Function
|
70
|
|
0.100 |
None |
|
0 |
|
|
|
Locally advanced breast cancer
|
disease |
|
Neoplastic Process
|
71
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hypogammaglobulinemia
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
76
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Recurrent aphthous ulcer
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
80
|
22
|
0.100 |
None |
|
0 |
|
|
|
Combined immunodeficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
86
|
11
|
0.300 |
strong |
1.000 |
1 |
|
2011 |
2011 |
MOHR-TRANEBJAERG SYNDROME
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Nervous System Diseases; Mental Disorders; Otorhinolaryngologic Diseases; Behavior and Behavior Mechanisms
|
Disease or Syndrome
|
89
|
19
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Acquired Hypogammaglobulinemia
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
89
|
4
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Oropharynx (excludes nasopharynx)
|
disease |
|
Disease or Syndrome
|
94
|
5
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Angioimmunoblastic Lymphadenopathy
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
109
|
8
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2014 |
Stomatitis
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
109
|
22
|
0.100 |
None |
|
0 |
|
|
|